Compare · head to head
Cronos Group vs Jones Lang LaSalle
Jones Lang LaSalle ranks higher overall — 360 rank 100 vs 45.
Jones Lang LaSalle leads on Value (75 vs 42), Quality (63 vs 38), Growth (60 vs 52) and Sentiment (62 vs 42). The two are close on Safety.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Canada | USA |
| Sector | Health Care | Real Estate |
| Industry | Pharmaceuticals | Real Estate Management & Development |
| Size | Small | Large |
| ISIN | CA22717L1013 | US48020Q1076 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 45 | 100 |
| Value | 42 | 75 |
| Quality | 38 | 63 |
| Growth | 52 | 60 |
| Safety | 70 | 73 |
| Sentiment | 42 | 62 |
| Quality details | ||
| Profitability | 27 | 75 |
| Cash Truth | 50 | 51 |
Cronos Group vs Curaleaf HoldingsCronos Group vs OrganiGram HoldingsCronos Group vs Canopy GrowthCronos Group vs Cresco LabsAdd a third stock →
Full analyses: Cronos Group · Jones Lang LaSalle
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100